BHCM
GUTS icon

Brevan Howard Capital Management’s Fractyl Health GUTS Stock Holding History

Brevan Howard Capital Management’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$719K Buy
916,321
+683,952
+294% +$487K 0.01% 1246
2026
Q1 		$99.2K Sell
232,369
-232,369
-50% -$214K ﹤0.01% 2025
2025
Q4 		$1.05M Buy
+464,738
New +$748K 0.01% 743

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Brevan Howard Capital Management's GUTS Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Fractyl Health (GUTS) stake by 294% in Q2 2026, buying an estimated $487K and bringing the position to 916,321 shares worth $719K. The position accounts for 0.01% of the portfolio, ranked #1246.

Brevan Howard Capital Management first reported a position in GUTS in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.05M in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Brevan Howard Capital Management held 916,321 shares of Fractyl Health worth $719K as of Q2 2026.
  • Brevan Howard Capital Management bought 683,952 Fractyl Health shares in Q2 2026, an estimated $487K.
  • Fractyl Health made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1246 holding.
  • Brevan Howard Capital Management first reported a position in Fractyl Health in Q4 2025 and has held it in 3 quarters since.
  • Brevan Howard Capital Management's Fractyl Health position peaked at $1.05M in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.